- Home
- IQV
as 11-15-2024 4:00pm EST
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
| Founded: | 1982 | Country: | United States |
| Employees: | N/A | City: | DURHAM |
| Market Cap: | 38.1B | IPO Year: | 2013 |
| Target Price: | $259.40 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 7.62 | EPS Growth: | 27.98 |
| 52 Week Low/High: | $189.63 - $261.73 | Next Earning Date: | 10-31-2024 |
| Revenue: | $15,315,000,000 | Revenue Growth: | 3.10% |
| Revenue Growth (this year): | 3.68% | Revenue Growth (next year): | 4.89% |
Stock Insider Trading Activity of IQVIA Holdings Inc. (IQV)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Sherbet Eric | IQV | See Remarks | Aug 27 '24 | Sell | $246.33 | 1,300 | $320,229.00 | 19,536 |
Latest IQVIA Holdings Inc. News
IQV Breaking Stock News: Dive into IQV Ticker-Specific Updates for Smart Investing
Business Wire
11 days ago
IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024
MT Newswires
11 days ago
Argus Cuts Price Target on IQVIA to $260 From $280
Argus Research
11 days ago
Analyst Report: IQVIA Holdings Inc
Argus Research
11 days ago
Market Digest: MAR, PGR, SHW, TROW, IQV, TWLO, NXPI
TipRanks
12 days ago
Iqvia price target lowered to $265 from $280 at Morgan Stanley
MT Newswires
12 days ago
JPMorgan Cuts Price Target on IQVIA to $240 From $279, Maintains Overweight Rating
Zacks
13 days ago
Interpreting IQVIA (IQV) International Revenue Trends
Argus Research
13 days ago
Weekly Stock List
Compare IQV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IQV IQVIA Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.